Ruizheng Gene
Latest round
- Seed
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 2
About Ruizheng Gene
Established in 2021 and based in Suzhou, China, Ruizheng Gene was founded to develop gene and RNA editing technologies for therapeutic applications. The founder, chairman, and CEO Dr. Yongzhong Wang has over 20 years of experience in biopharmaceutical innovation, having held leadership roles at CMAB BioPharma (Suzhou), Simcere Pharmaceutical Group, and Chengdu Kanghong Biotechnology. Co-founder and head of CMC, Dr. Jialin Tao, previously worked at Roche, CMC Biologics, Simcere, and CMAB. The company develops innovative drug candidates and treatment solutions targeting intracellular and nuclear disease mechanisms. Its core technologies include gene editing, RNA editing and delivery platforms integrated with off-target analysis and process development for congenital and acquired disease therapies. The company generates revenue through partnerships, licensing, and early-stage therapeutic product development focused on genetic and RNA-based treatments.
Who invested in Ruizheng Gene
2 investors across 1 round
See all investors in Ruizheng Gene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Sep 9, 2021
Amount
Undisclosed
Investors
Questions about Ruizheng Gene
Who invested in Ruizheng Gene?
Ruizheng Gene has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruizheng Gene raised?
Ruizheng Gene has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ruizheng Gene last raise money?
Ruizheng Gene's most recent round on record is a Seed, in Sep 2021.
What does Ruizheng Gene do?
Established in 2021 and based in Suzhou, China, Ruizheng Gene was founded to develop gene and RNA editing technologies for therapeutic applications.
Where is Ruizheng Gene headquartered?
Ruizheng Gene is headquartered in Suzhou, China.
Which VCs invest in companies like Ruizheng Gene?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Ruizheng Gene's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Ruizheng Gene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.